API Pharma

02/25/2022

07/23/2020

05/19/2020

Recent studies found that T cells found in COVID-19 patients ‘bode well’ for long-term immunity.

T cells are a type of white blood cell that the immune system uses to help fight viruses.

Scientists found that in people who had recovered from COVID-19, the T cells react to SARS-CoV-2 virus, the cause of the disease.

This study reveals new information that will help researchers better understand immunity.

Read the full story: https://www.sciencemag.org/news/2020/05/t-cells-found-covid-19-patients-bode-well-long-term-immunity?fbclid=IwAR2JomL5K_XZ2K8eq9Z1FjIWZG2AsIWlINmq5o8nm6iaPpYDYMqfMvnErNc #

New findings suggest past infections may offer some protection against the novel coronavirus

05/11/2020

Hear from our founder Dr. Vincent DeGennaro on the Pensacola Morning News on NewsRadio1620.

Dr. DeGennaro and Andrew McKay discuss the way API's Covid-rapid works and how it solves for some of the concerns about accuracy for antibody tests that look for the novel coronavirus.

Listen to the interview below and learn more on our website https://covid-rapid.com

Andrew McKay and Dr. DeGennero (Epidemiologist and Medical Director/CEO of Abacus Pharma International) discuss the new rapid COVID-19 antibody test from Sure Bio-Tech and distributed by API which fun

05/06/2020

In a breakthrough study about immunity, South Korean scientists found that people cannot be infected twice with the virus. This result means that once a person has had Covid-19 (even if they are asymptomatic), they will be immune in the future.

Tests like Covid-Rapid are critical in understanding who has the antibodies that indicate this immunity. Once a person has been exposed to the virus, antibodies develop, and Covid-Rapid detects the presence of these antibodies in just ten minutes.

Read the whole story: https://news.sky.com/story/amp/coronavirus-scientists-conclude-people-cannot-be-infected-twice-11981721

Learn more about Covid-Rapid on our website: https://www.covid-rapid.com

A total of 277 patients in the country were believed to have fallen ill for a second time, as had patients in China and Japan.

05/04/2020

CBS Miami Host Joan Murray gets a test administered to her on live television.

“After 10 minutes you know whether you’ve been exposed to the virus and are currently immune or are currently infected,” Dr. Vince DeGennaro, API’s Medical Director, explained.

API's Covid-Rapid tests have been found in multiple studies to have 0 false positives.

See the full story here: https://miami.cbslocal.com/2020/04/30/joan-murray-firsthand-look-coronavirus-antibody-test-administered/

04/27/2020

Antibody testing is vital for understanding who in a community has previously been exposed to COVID-19, which can help scientists understand potential immunity and the actual infection rate. But not all antibody tests are created equally, and some are not as accurate as others.

Covid-Rapid wants to keep you informed. We are committed to transparency and accurate results.

“Every scrap of data I have is public,” API's medical director Dr. Vincent DeGennaro said. “We put our data on the website — good, bad, ugly, it’s there.” According to another study, published by researchers at UCSF, UC Berkeley, and Harvard, Covid-Rapid was found to have 100% specificity, meaning zero false positives.

Read the full story: https://www.palmbeachpost.com/news/20200424/coronavirus-florida-why-antibody-tests-are-getting-attention-for-results-and-accuracy

Learn more about API's on our website: http://covid-rapid.com

The emphasis on coronavirus testing has been to determine whether a person was actively ill. Now tests to spot antibodies for COVID-19 in people are

04/24/2020

New estimates by researchers at Harvard University suggest that the U.S. cannot safely reopen without conducting 20 million tests per day for COVID-19. The U.S. has currently conducted around 4 million tests total. The report says that this enormous increase in testing is the only solution that both contains the virus and allows the economy to ramp back up.

"The fundamental element of keeping our economy open is making sure you’re identifying as many infected people as possible and isolating them," Ashish Jha, the director of the Harvard Global Health Institute said.

Affordable, accurate, and rapid antibody tests like Covid-Rapid's 15-minute point-of-care test will be instrumental in identifying those who have been exposed to the virus and who may have relative immunity. This information is crucial for doctors and scientists to better understand the actual rate of infection and spread of the virus.

Read more from about the necessity of increased testing for economic reopening: https://thehill.com/policy/healthcare/493722-us-needs-to-conduct-20-million-coronavirus-tests-per-day-to-fully-open

Learn more about Covid-Rapid on our website and by following our page https://covid-rapid.com

The U.S.

04/22/2020

“We’ve been in use in Europe. We have great studies done by independent researchers demonstrating the efficacy of the test,” said API CEO Dr. Vincent DeGennaro.

“What sets us apart is production capability and quality. We can make 20 million tests a month,” he says.

https://miami.cbslocal.com/2020/04/21/thousands-of-covid-antibody-tests-arriving-in-south-florida-this-week/

Antibody testing is seen as a key component to restarting South Florida’s economy in the wake of the coronavirus pandemic.

04/22/2020

Dana Perino hosts API Medical Director Vincent DeGennaro on Fox News' "The Daily Briefing" to discuss rapid-testing in America, and what API is doing to get America back to work!

Source: Fox News

https://covid-rapid.com/blogs/covid-rapid-in-the-news/fox-news-daily-briefing-with-dana-perino-hosts-api-medical-director-vincent-degennaro-and-asks-are-antibody-tests-the-key-to-returning-to-normal

Fox News Daily Briefing with Dana Perino Hosts API Medical Director Vincent DeGennaro and asks

04/21/2020

Tune-in to The Daily Briefing with Dana Perino at 2:00PM to hear API's Medical Director, Dr. Vincent DeGennaro, discuss rapid testing in the United States, and how it will help get America back to work. Find out more about our test at www.covid-rapid.com !

04/20/2020

There are a wide variety of serology tests, but API's track record of having developed more than 200 rapid tests distributed around the world over the past 10 years demonstrates its reliability and repeated success with testing.

Tens of thousands of API’s Covid-Rapid tests have been used in Switzerland and Belgium, where studies have provided in vivo data. Serology tests screen for antibodies, which form several days after infection of COVID-19, so the test is best used to screen for previous infection, rather than current infection.

No test is perfect, but when used properly, Covid-Rapid can be used as an immunity test that produces a very low rate of false positives.

Covid-Rapid has demonstrated 95% to 100% accuracy in identifying infected patients after Day 12. Antibody testing is critical for understanding who might have developed immunity, and therefore, who might be able to return to work.

Learn more on our website: http://covid-rapid.com

API provides a rapid covid-19 antibody test kit.

04/17/2020

A recent study at a homeless shelter in Boston found that close to 40% of the people tested for COVID-19 were positive. Shockingly, NONE showed symptoms.

This study indicates how many people infected with the virus might not know it. Even if a person is asymptomatic, they can still spread the virus.

Antibody testing, like our 15-minute Covid-Rapid test, is absolutely necessary for understanding who might have been infected without knowing it. Many people who seek swab testing already show symptoms, meaning huge numbers of people with COVID-19 are not getting tested and are still spreading the virus.

Our rapid-test requires only a few drops of blood and no outside equipment or lab testing, and results come in just 15 minutes. Learn more about it on our website.

Read more about the study here: https://www.boston25news.com/news/cdc-reviewing-stunning-universal-testing-results-boston-homeless-shelter/Z253TFBO6RG4HCUAARBO4YWO64/

The Centers for Disease Control and Prevention is now “actively looking into” results from universal COVID-19 testing at Pine Street Inn homeless shelter.

04/17/2020

From our team of medical professionals at API, we offer our heartfelt thanks for those on the frontlines of the COVID-19 pandemic. We feel your pain and we hear your needs.

That's why we are working expeditiously -- negotiating global supply chain and regulatory challenges -- to get our test-kits in the hands of those who need it most. Until then, please spread the word. Public health experts and politicians alike agree that rapid testing will be essential to alleviating the stress on our public healthcare system, and it is what our frontline workers need.

We invite medical providers to read more about the science behind our new 15-minute IgG/IgM COVID-RAPID serology test on our dedicated page for providers. Thank you for doing your part to put America back to work.

Find out more by visiting www.covid-rapid.com

API provides a rapid covid-19 antibody test kit.

04/16/2020

At Tuesday's daily press briefing, White House officials announced, “a new antibody test may well be approved by the FDA in just a matter of days...an antibody test that would be produced at the rate of 20 million tests a month."

API has confirmed with the White House that the Vice President was referring to the manufacturing capacity of API and its new serology "immunity" test kits, called Covid-Rapid.

Covid-Rapid, registered last week by the FDA, is a rapid antibody test which gives patients results in less than 15-minutes, with no need for lab equipment. Read more about Covid-Rapid and how it will help put America back to work at www.covid-rapid.com

API provides a rapid covid-19 antibody test kit.

04/15/2020

Vice President Mike Pence referenced our COVID-RAPID test-kits at his daily press briefing yesterday, our staff writer confirmed. COVID-RAPID is a 15-minute point-of-care finger-prick test for COVID-19, registered by the FDA, that will be essential to reopening America. We expect to have unparalleled manufacturing capacity to help put America back to work! Check out this story and more like it by visiting our website or by liking our page.

https://covid-rapid.com/blogs/washington-post/the-daily-wire-pence-announces-20-million-antibody-coronavirus-tests-to-be-made-per-month

By: Staff WriterSource: The White House On Tuesday, at his daily press briefing, Vice President Mike Pence referenced API's Covid-Rapid test. “A point that I will ask Dr. Birx to expand on in just a moment is that fact that beyond the new 15-minute tests by Abbott laboratories, beyond what we expe...

04/09/2020

Watch Dr. Vincent DeGennaro, our medical director, on NBC tonight discussing our COVID-RAPID test, now registered by the FDA for sale to medical professionals!

API plans to donate 10,000 tests to the city of Miami. "This is not about selling tests for us," Dr. DeGennaro, an epidemiologist, exclaims. "This is about helping people get back to work and repair a damaged economy and minimize the impact the disease can have in our community here in Miami."

API's COVID-RAPID test is especially useful as a screening test to see who has immunity within a certain community, serving as the most productive means to track the spread of the virus.

See the full interview here:
https://covid-rapid.com/blogs/washington-post/nbc6-south-florida-company-says-rapid-test-can-screen-for-covid-19-antibodies

As companies race to get rapid COVID-19 tests approved by the Food and Drug Administration, one in South Florida says theirs can produce quick results that can get people back to work and help those on the front lines.

04/08/2020

API's Covid-Rapid test kits as of today are registered by the FDA to sell to medical facilities to help accelerate widespread testing throughout the U.S. Serology tests like ours help test for immunity, unlike current swab testing.

Many states face test shortages, which mean doctors and officials are often making treatment plans and policy without enough information. With the availability of quick, easy, and affordable tests like ours that don't require any outside lab equipment, more people can access testing to see if they are currently infected with COVID-19 or had been in the past.

Knowledge previous infection is critical for understanding potential immunity, which will allow people to safely go back to work.

Learn more on our website: http://covid-rapid.com and in the news: https://www.nbcmiami.com/news/local/south-florida-company-creates-rapid-antibody-test-for-covid-19/2217449/

API provides a rapid covid-19 antibody test kit.

04/06/2020

As the U.S. death toll approaches 10,000, it is hard to maintain optimism. However, the nation's top Coronavirus expert, Dr. Anthony Fauci, is very confident that survivors will develop immunity, whether or not they were symptomatic to begin with. That is why serology tests such as COVID-RAPID will be absolutely essential in restarting the economy and restoring normalcy. Without these tests, the nation would be substantially more susceptible to reinfection and a prolonged social stagnation. https://covid-rapid.com/

API provides a rapid covid-19 antibody test kit.

04/04/2020

Check out this article that reinforces the importance of serology tests in dampening the extent of this horrible pandemic we are in. Quick, affordable, and scalable, COVID-RAPID tests reveal who has had the virus and is now relatively immune -- these people can be at the forefront of efforts to reopen America. https://www.washingtonpost.com/health/2020/03/31/coronavirus-serology-blood-tests/

Find similar articles on our website: www.covid-rapid.com

Serology tests that measure coronavirus antibodies could restart society, but this will require accurate, widespread testing and more information about immunity.

03/31/2020

How will API's new COVID-RAPID 15-minute test for COVID-19 help put America back to work?

Unlike the swab (PCR) tests, our test looks for both current AND past infections. If both antibodies are positive, you have a current infection. If only the long-lasting antibody (IgG) is positive, then we know that your infection is likely more than three weeks old. But that means that you likely have immunity to getting infected again, at least for the next 12 months, and you are no longer contagious. This will help public health officials limit the spread while allowing people who have demonstrated relative immunity to jump start their lives again!

Find out more about this and other questions at https://covid-rapid.com/pages/faqs-1

Q: When will you receive FDA approval? A: President Trump asked the FDA to “cut the red tape,” and facilitate approval for new COVID-19 treatment and testing. In order to accelerate the review process, the FDA is providing “Emergency Use Authorization” (EUA) to products that meet requirement...

03/30/2020

Spread the word! Our new page is live for the product debut of COVID-RAPID, a 15-minute rapid test for COVID-19. This new point-of-care antibody test will provide fast results in 15 minutes, while the user waits in the doctor’s office. This simple test involves a finger prick. A reagent is added to a few drops of blood, and in 15 minutes the results appear on the test: one line if negative and two if positive for COVID-19. Learn more about our test and why it will put America back to work by visiting our new page.

03/30/2020

Let's put America back to work with our new COVID-19 rapid test.

Yesterday at his daily press conference, New York Governor Andrew Cuomo said that when a point-of-care test becomes widely available, America will be able to "return to normalcy in the workforce." We've risen to the call and developed a 15-minute rapid antibody test for COVID-19 that will be available soon. Now we just need you to spread the word. Find out more on our page or at www.covid-rapid.com.

03/30/2020

API's new COVID-RAPID test for COVID-19 is an antibody test, which is different from the PCR tests you've been seeing in the news. Covid-Rapid works by looking for antibodies in your blood to the virus. So no uncomfortable deep nose or throat swab (PCR test) and more importantly, you know for sure that the sample collected is properly done, which isn’t always true with the swabs. By placing the blood on the strip with the reagent, capillary action takes the water part of your blood, which contains the antibodies, down the strip to interact with pieces of the virus embedded in the paper. If you have antibodies to the virus in your blood, they will react with these pieces of the virus, changing the color of the paper. This will show a line indicating a positive result, just like a pregnancy test.

API provides a rapid covid-19 antibody test kit.

03/30/2020

BREAKING: API'S 15-MINUTE COVID-19 TEST AVAILABLE SOON. Abacus Pharma International (API) has launched a rapid diagnostic test for COVID-19, the novel coronavirus. This new point-of-care antibody test will provide fast results in 15 minutes, while the user waits in the doctor’s office. This simple test involves a finger prick. A reagent is added to a few drops of blood, and in 15 minutes the results appear on the test: one line if negative and two if positive for COVID-19. Learn more about our test and why it will put America back to work by visiting our website www.covid-rapid.com